Our findings reveal that C1QA, C1QB, LYN, CD68, LAPTM5, IFI30, PI3KAP1, HCK, and ARHGDIB are significantly associated with oxidative damage and immune response, which may be novel biomarkers involved in AD. Here, LAPTM5 is linked to Alzheimer disease.